{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T14:20:29Z","timestamp":1790000429054,"version":"4.0.1"},"reference-count":68,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81501429"],"award-info":[{"award-number":["81501429"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.vaccine.2024.01.075","type":"journal-article","created":{"date-parts":[[2024,2,5]],"date-time":"2024-02-05T15:28:36Z","timestamp":1707146916000},"page":"1549-1560","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Mechanism study of cross presentation of exogenous antigen induced by cholera toxin-like chimeric protein"],"prefix":"10.1016","volume":"42","author":[{"given":"Xianying","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaixiang","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyan","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingqin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingsong","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junjie","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ximing","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peifang","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujing","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huaqian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2024.01.075_b0005","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA-Cancer J Clin"},{"key":"10.1016\/j.vaccine.2024.01.075_b0010","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.biopha.2020.110640","article-title":"Cancer neoantigen: Boosting immunotherapy","volume":"131","author":"Xu","year":"2020","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.vaccine.2024.01.075_b0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.coi.2019.12.005","article-title":"Cross-presentation of exogenous antigens on MHC I molecules","volume":"64","author":"Colbert","year":"2020","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.vaccine.2024.01.075_b0020","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1016\/j.biopha.2017.11.126","article-title":"Recent advances in cancer immunology and immunology-based anticancer therapies","volume":"96","author":"Kumar","year":"2017","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.vaccine.2024.01.075_b0025","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1016\/j.vaccine.2011.12.120","article-title":"Antigen delivery for cross priming via the emulsion vaccine adjuvants","volume":"30","author":"Shen","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.01.075_b0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.biomaterials.2019.03.037","article-title":"Nanovaccine based on a protein-delivering dendrimer for effective antigen cross-presentation and cancer immunotherapy","volume":"207","author":"Xu","year":"2019","journal-title":"Biomaterials"},{"key":"10.1016\/j.vaccine.2024.01.075_b0035","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.tibtech.2018.10.004","article-title":"Applications of immunomodulatory immune synergies to adjuvant discovery and vaccine development","volume":"37","author":"Tom","year":"2019","journal-title":"Trends Biotechnol"},{"key":"10.1016\/j.vaccine.2024.01.075_b0040","doi-asserted-by":"crossref","first-page":"974","DOI":"10.3390\/toxins7030974","article-title":"Cholera toxin B: One subunit with many pharmaceutical applications","volume":"7","author":"Baldauf","year":"2015","journal-title":"Toxins"},{"key":"10.1016\/j.vaccine.2024.01.075_b0045","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.coph.2018.03.015","article-title":"ADP-ribosylating enterotoxins as vaccine adjuvants","volume":"41","author":"Lycke","year":"2018","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.vaccine.2024.01.075_b0050","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.1002\/1521-4141(2000)30:8<2394::AID-IMMU2394>3.0.CO;2-Y","article-title":"Cholera toxin induces maturation of human dendritic cells and licences them for Th2 priming","volume":"30","author":"Gagliardi","year":"2000","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.vaccine.2024.01.075_b0055","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/S0264-410X(02)00532-7","article-title":"Maturation of human dendritic cells induced by the adjuvant cholera toxin: role of cAMP on chemokine receptor expression","volume":"21","author":"Gagliardi","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.01.075_b0060","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0178114","article-title":"Low doses of cholera toxin and its mediator cAMP induce CTLA-2 secretion by dendritic cells to enhance regulatory T cell conversion","volume":"12","author":"Silva-Vilches","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2024.01.075_b0065","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1046\/j.1365-2222.2000.00849.x","article-title":"Prolonged oral treatment with low doses of allergen conjugated to cholera toxin B subunit suppresses immunoglobulin E antibody responses in sensitized mice","volume":"30","author":"Rask","year":"2000","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.vaccine.2024.01.075_b0070","doi-asserted-by":"crossref","first-page":"8451","DOI":"10.1016\/j.vaccine.2011.07.077","article-title":"Cholera toxin B subunit linked to glutamic acid decarboxylase suppresses dendritic cell maturation and function","volume":"29","author":"Odumosu","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.01.075_b0075","doi-asserted-by":"crossref","first-page":"3360","DOI":"10.1016\/S0264-410X(00)00532-6","article-title":"Effect of pre-existing immunity for systemic and mucosal immune responses to intranasal immunization with group B Streptococcus type III capsular polysaccharide-cholera toxin B subunit conjugate","volume":"19","author":"Shen","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.01.075_b0080","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.vaccine.2016.11.055","article-title":"Kinetics of antibody-secreting cell and fecal IgA responses after oral cholera vaccination in different age groups in a cholera endemic country","volume":"35","author":"Akhtar","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.01.075_b0085","doi-asserted-by":"crossref","first-page":"5079","DOI":"10.1016\/j.vaccine.2008.03.096","article-title":"Enhancement of epitope-specific cellular immune responses by immunization with HIV-1 peptides genetically conjugated to the B-subunit of recombinant cholera toxin","volume":"26","author":"Boberg","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.01.075_b0090","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1083\/jcb.131.4.951","article-title":"Targeting of cholera toxin and Escherichia coli heat labile toxin in polarized epithelia: role of COOH-terminal KDEL","volume":"131","author":"Lencer","year":"1995","journal-title":"J Cell Biol"},{"key":"10.1016\/j.vaccine.2024.01.075_b0095","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1007\/s00018-008-7496-5","article-title":"Cholera toxin structure, gene regulation and pathophysiological and immunological aspects","volume":"65","author":"Sanchez","year":"2008","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.vaccine.2024.01.075_b0100","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1128\/JVI.80.4.1752-1761.2006","article-title":"Rectal immunization with rotavirus virus-like particles induces systemic and mucosal humoral immune responses and protects mice against rotavirus infection","volume":"80","author":"Parez","year":"2006","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2024.01.075_b0105","doi-asserted-by":"crossref","first-page":"3823","DOI":"10.1128\/JVI.80.8.3823-3832.2006","article-title":"Intrarectal immunization with rotavirus 2\/6 virus-like particles induces an antirotavirus immune response localized in the intestinal mucosa and protects against rotavirus infection in mice","volume":"80","author":"Agnello","year":"2006","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2024.01.075_b0110","doi-asserted-by":"crossref","first-page":"3513","DOI":"10.1016\/j.vaccine.2018.04.067","article-title":"Immunogenicity of a Staphylococcus aureus-cholera toxin A(2)\/B vaccine for bovine mastitis","volume":"36","author":"Misra","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.01.075_b0115","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1128\/CVI.05146-11","article-title":"Mucosal immunization with a Staphylococcus aureus IsdA-cholera toxin A(2)\/B chimera induces antigen-specific Th2-type responses in mice","volume":"18","author":"Arlian","year":"2011","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2024.01.075_b0120","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.3390\/toxins6041397","article-title":"Immunogenicity of a West Nile virus DIII-cholera toxin A(2)\/B chimera after intranasal delivery","volume":"6","author":"Tinker","year":"2014","journal-title":"Toxins"},{"key":"10.1016\/j.vaccine.2024.01.075_b0125","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.pep.2010.04.021","article-title":"Purification and characterization of Yersinia enterocolitica and Yersinia pestis LcrV-cholera toxin A(2)\/B chimeras","volume":"74","author":"Tinker","year":"2010","journal-title":"Protein Expr Purif"},{"key":"10.1016\/j.vaccine.2024.01.075_b0130","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1016\/j.vaccine.2021.02.002","article-title":"Co-delivery of PSMA antigen epitope and mGM-CSF with a cholera toxin-like chimeric protein suppressed prostate tumor growth via activating dendritic cells and promoting CTL responses","volume":"39","author":"Lin","year":"2021","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.01.075_b0135","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1093\/annonc\/mdu211","article-title":"Final report of the phase I\/II clinical trial of the E75 (nelipepimut-S) vaccine with booster inoculations to prevent disease recurrence in high-risk breast cancer patients","volume":"25","author":"Mittendorf","year":"2014","journal-title":"Ann Oncol"},{"key":"10.1016\/j.vaccine.2024.01.075_b0140","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1038\/nm.2883","article-title":"Multipeptide immune response to cancer vaccine IMA901 after single-dose cyclophosphamide associates with longer patient survival","volume":"18","author":"Walter","year":"2012","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2024.01.075_b0145","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1084\/jem.176.6.1693","article-title":"Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte\/macrophage colony-stimulating factor","volume":"176","author":"Inaba","year":"1992","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2024.01.075_b0150","series-title":"Current Protocols in Immunology","first-page":"3.7.7","article-title":"Generation of dendritic cells from proliferating mouse bone marrow progenitors","author":"Inaba","year":"1997"},{"key":"10.1016\/j.vaccine.2024.01.075_b0155","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.pep.2005.09.027","article-title":"Single step protocol to purify recombinant proteins with low endotoxin contents","volume":"46","author":"Reichelt","year":"2006","journal-title":"Protein Expr Purif"},{"key":"10.1016\/j.vaccine.2024.01.075_b0160","doi-asserted-by":"crossref","first-page":"690","DOI":"10.3109\/08820130903124770","article-title":"Immunotherapy of autoimmune diabetes by nasal Administration of tandem glutamic acid decarboxylase 65 peptides","volume":"38","author":"Wang","year":"2009","journal-title":"Immunol Invest"},{"key":"10.1016\/j.vaccine.2024.01.075_b0165","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.pep.2016.03.007","article-title":"Purification and characterization of a novel cell-penetrating carrier similar to cholera toxin chimeric protein","volume":"129","author":"Lin","year":"2017","journal-title":"Protein Expr Purif"},{"key":"10.1016\/j.vaccine.2024.01.075_b0170","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.jconrel.2020.03.027","article-title":"An in vitro and in vivo study of the brain-targeting effects of an epidermal growth factor-functionalized cholera toxin-like chimeric protein","volume":"322","author":"He","year":"2020","journal-title":"J Control Release"},{"key":"10.1016\/j.vaccine.2024.01.075_b0175","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1586\/14789450.4.3.355","article-title":"Discontinuous native protein gel electrophoresis: pros and cons","volume":"4","author":"Niepmann","year":"2007","journal-title":"Expert Rev Proteomics"},{"key":"10.1016\/j.vaccine.2024.01.075_b0180","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jconrel.2009.12.003","article-title":"Enhancement of TAT cell membrane penetration efficiency by dimethyl sulphoxide","volume":"143","author":"Wang","year":"2010","journal-title":"J Control Release"},{"key":"10.1016\/j.vaccine.2024.01.075_b0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2019.115172","article-title":"Chitosan\/calcium phosphates nanosheet as a vaccine carrier for effective cross-presentation of exogenous antigens","volume":"224","author":"Pei","year":"2019","journal-title":"Carbohydr Polym"},{"key":"10.1016\/j.vaccine.2024.01.075_b0190","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.imbio.2012.01.021","article-title":"The mouse dendritic cell marker CD11c is down-regulated upon cell activation through Toll-like receptor triggering","volume":"218","author":"Singh-Jasuja","year":"2013","journal-title":"Immunobiology"},{"key":"10.1016\/j.vaccine.2024.01.075_b0195","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1126\/science.adg8802","article-title":"Perforin-2 is a pore-forming effector of endocytic escape in cross-presenting dendritic cells","volume":"380","author":"Rodr\u00edguez-Silvestre","year":"2023","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2024.01.075_b0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2020.101007","article-title":"Nanovaccines integrating endogenous antigens and pathogenic adjuvants elicit potent antitumor immunity","volume":"35","author":"Li","year":"2020","journal-title":"Nano Today"},{"key":"10.1016\/j.vaccine.2024.01.075_b0205","article-title":"Programmed nanoparticle-loaded microparticles for effective antigen\/adjuvant delivery","author":"Xu","year":"2021","journal-title":"Particuology"},{"key":"10.1016\/j.vaccine.2024.01.075_b0210","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.omto.2021.10.003","article-title":"Mycobacterium tuberculosis Rv3628 isan effective adjuvant via activationof dendritic cells for cancer immunotherapy","volume":"23","author":"Wu","year":"2021","journal-title":"Mol Therapy Oncolytics"},{"key":"10.1016\/j.vaccine.2024.01.075_b0215","doi-asserted-by":"crossref","first-page":"27528","DOI":"10.1073\/pnas.2006186117","article-title":"Selective tumor antigen vaccine delivery to human CD169(+) antigen-presenting cells using ganglioside-liposomes","volume":"117","author":"Affandi","year":"2020","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2024.01.075_b0220","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1128\/iai.61.2.384-390.1993","article-title":"Reduction in oral immunogenicity of cholera toxin B subunit by N-terminal peptide addition","volume":"61","author":"Dertzbaugh","year":"1993","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2024.01.075_b0225","doi-asserted-by":"crossref","first-page":"5019","DOI":"10.1016\/j.vaccine.2014.07.016","article-title":"Cholera toxin B subunit-Five-stranded alpha-helical coiled-coil fusion protein: \u201cFive-to-five\u201d molecular chimera displays robust physicochemical stability","volume":"32","author":"Arakawa","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.01.075_b0230","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0230138","article-title":"Biochemical and immunological characterization of an ETEC CFA\/I adhesin cholera toxin B subunit chimera","volume":"15","author":"Jobling","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2024.01.075_b0235","doi-asserted-by":"crossref","first-page":"4225","DOI":"10.1016\/j.vaccine.2012.04.047","article-title":"Physicochemically stable cholera toxin B subunit pentamer created by peripheral molecular constraints imposed by de novo-introduced intersubunit disulfide crosslinks","volume":"30","author":"Miyata","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.01.075_b0240","doi-asserted-by":"crossref","first-page":"14084","DOI":"10.1021\/jacs.5b05694","article-title":"Discovery and characterization of a peptide that enhances endosomal escape of delivered proteins in vitro and in vivo","volume":"137","author":"Li","year":"2015","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.vaccine.2024.01.075_b0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.talanta.2020.121572","article-title":"Self-assembled peptide nanoparticles with endosome escaping permits for co-drug delivery","volume":"221","author":"Guo","year":"2021","journal-title":"Talanta"},{"key":"10.1016\/j.vaccine.2024.01.075_b0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2022.114544","article-title":"Recombinant protein polymers as carriers of chemotherapeutic agents","author":"Phour","year":"2022","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.vaccine.2024.01.075_b0255","doi-asserted-by":"crossref","DOI":"10.1016\/j.progpolymsci.2023.101751","article-title":"Functionalization of polymers for intracellular protein delivery","author":"Zhang","year":"2023","journal-title":"Prog Polym Sci"},{"key":"10.1016\/j.vaccine.2024.01.075_b0260","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/j.ijbiomac.2020.02.215","article-title":"B subunit of cholera toxin fused with VP7 from GCRV (grass carp reovirus) was expressed in E. coli and folds into an active protein","volume":"151","author":"Zhao","year":"2020","journal-title":"Int J Biol Macromol"},{"key":"10.1016\/j.vaccine.2024.01.075_b0265","doi-asserted-by":"crossref","first-page":"29953","DOI":"10.1074\/jbc.270.50.29953","article-title":"Kinetics of acid-mediated disassembly of the B subunit pentamer of Escherichia coli heat-labile enterotoxin","volume":"270","author":"Ruston","year":"1995","journal-title":"J Biol Chem"},{"key":"10.1016\/j.vaccine.2024.01.075_b0270","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1016\/S0140-6736(17)30559-7","article-title":"Cholera","volume":"390","author":"Clemens","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2024.01.075_b0275","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.jconrel.2019.10.031","article-title":"Self-assembled peptide nanoparticles responsive to multiple tumor microenvironment triggers provide highly efficient targeted delivery and release of antitumor drug","volume":"316","author":"Jiang","year":"2019","journal-title":"J Control Release"},{"key":"10.1016\/j.vaccine.2024.01.075_b0280","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0092-8674(00)80341-4","article-title":"Bidirectional transport by distinct populations of COPI-coated vesicles","volume":"90","author":"Orci","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.vaccine.2024.01.075_b0285","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1126\/science.8128252","article-title":"Coatomer interaction with di-lysine endoplasmic reticulum retention motifs","volume":"263","author":"Cosson","year":"1994","journal-title":"Science (New York, NY)"},{"key":"10.1016\/j.vaccine.2024.01.075_b0290","doi-asserted-by":"crossref","first-page":"12339","DOI":"10.1073\/pnas.93.22.12339","article-title":"Thapsigargin-induced transport of cholera toxin to the endoplasmic reticulum","volume":"93","author":"Sandvig","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2024.01.075_b0295","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jdermsci.2009.04.008","article-title":"HPV16E7 tumor antigen modified by KDEL sequence induce specific cytotoxic T lymphocytes-dependent antitumor immunity","volume":"55","author":"Yin","year":"2009","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.vaccine.2024.01.075_b0300","doi-asserted-by":"crossref","first-page":"S748","DOI":"10.4103\/0973-1482.199445","article-title":"Human colorectal cancer antigen GA733-2-Fc fused to endoplasmic reticulum retention motif KDEL enhances its immunotherapeutic effects","volume":"14","author":"Fu","year":"2018","journal-title":"J Cancer Res Ther"},{"key":"10.1016\/j.vaccine.2024.01.075_b0305","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.procbio.2020.10.018","article-title":"Isolation and detection of a KDEL-tagged recombinant cholera toxin B subunit from Nicotiana benthamiana","volume":"101","author":"Morris","year":"2021","journal-title":"Process Biochem"},{"issue":"3","key":"10.1016\/j.vaccine.2024.01.075_b0310","doi-asserted-by":"crossref","first-page":"e2046","DOI":"10.1371\/journal.pntd.0002046","article-title":"Rapid and scalable plant-based production of a cholera toxin B subunit variant to aid in mass vaccination against cholera outbreaks","volume":"7","author":"Hamorsky","year":"2013","journal-title":"PLoS Neglected Tropical Dis"},{"key":"10.1016\/j.vaccine.2024.01.075_b0315","first-page":"314","article-title":"Raft trafficking of AB(5) subunit bacterial toxins","volume":"1746","author":"Lencer","year":"2005","journal-title":"BBA-Mol Cell Res"},{"key":"10.1016\/j.vaccine.2024.01.075_b0320","first-page":"133","article-title":"Development of dendritic cells from GM-CSF-\/- mice in vitro: GM-CSF enhances production and survival of cells","volume":"8","author":"Ni","year":"2001","journal-title":"Dev Immunol"},{"key":"10.1016\/j.vaccine.2024.01.075_b0325","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.molimm.2018.05.017","article-title":"Modular MLV-VLPs co-displaying ovalbumin peptides and GM-CSF effectively induce expansion of CD11b(+) APC and antigen-specific T cell responses in vitro","volume":"101","author":"Gogesch","year":"2018","journal-title":"Mol Immunol"},{"key":"10.1016\/j.vaccine.2024.01.075_b0330","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/j.immuni.2015.11.006","article-title":"Toll-like receptor 4 engagement on dendritic cells restrains phago-lysosome fusion and promotes cross-presentation of antigens","volume":"43","author":"Alloatti","year":"2015","journal-title":"Immunity"},{"key":"10.1016\/j.vaccine.2024.01.075_b0335","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.molimm.2020.02.018","article-title":"Enhanced efficacy of a multi-epitope vaccine for type A and O foot-and-mouth disease virus by fusing multiple epitopes with Mycobacterium tuberculosis heparin-binding hemagglutinin (HBHA), a novel TLR4 agonist","volume":"121","author":"Lei","year":"2020","journal-title":"Mol Immunol"},{"key":"10.1016\/j.vaccine.2024.01.075_b0340","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/j.trecan.2021.06.007","article-title":"Immunity beyond cancer cells: perspective from tumor tissue","volume":"7","author":"Gao","year":"2021","journal-title":"Trends Cancer"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X24001002?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X24001002?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:34:56Z","timestamp":1759404896000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X24001002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":68,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S0264410X24001002"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.01.075","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mechanism study of cross presentation of exogenous antigen induced by cholera toxin-like chimeric protein","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.01.075","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}